These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26600755)

  • 1. Simplest identification, O-specific polysaccharide purification and antigenic evaluation of Salmonella enterica serovar Typhi Vi negative isolate.
    Salman M; Ali A; Jabbar A; Sarwar Y; Rahman M; Iqbal M; Haque A
    EXCLI J; 2015; 14():1078-84. PubMed ID: 26600755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and antigenic detection of O-specific polysaccharides of
    Rahmat Z; Ali A; Sarwar Y; Salman M; Haque A
    Springerplus; 2016; 5(1):1954. PubMed ID: 27933236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan.
    Baker S; Sarwar Y; Aziz H; Haque A; Ali A; Dougan G; Wain J; Haque A
    J Clin Microbiol; 2005 Sep; 43(9):4418-25. PubMed ID: 16145086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
    Haque A
    Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First characterization of immunogenic conjugates of Vi negative Salmonella Typhi O-specific polysaccharides with rEPA protein for vaccine development.
    Salman M; St Michael F; Ali A; Jabbar A; Cairns C; Hayes AC; Rahman M; Iqbal M; Haque A; Cox AD
    J Immunol Methods; 2017 Nov; 450():27-33. PubMed ID: 28735760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of a highly purified capsular polysaccharide from Salmonella enterica serovar Typhi (Salmonella typhi)--Vi-antigen and its use in serological diagnosis of typhoid fever].
    Tesheva AM; Aparin PG; L'vov VL
    Bioorg Khim; 2002; 28(1):64-8. PubMed ID: 11875976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vi Capsular Polysaccharide of Salmonella Typhi Promotes Macrophage Phagocytosis by Binding the Human C-Type Lectin DC-SIGN.
    Zhang LF; Lepenies B; Nakamae S; Young BM; Santos RL; Raffatellu M; Cobb BA; Hiyoshi H; Bäumler AJ
    mBio; 2022 Dec; 13(6):e0273322. PubMed ID: 36286551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi.
    Kothari S; Kothari N; Kim JA; Lee E; Yoon YK; An SJ; Jones C; Choe WS; Carbis R
    Vaccine; 2013 Oct; 31(42):4714-9. PubMed ID: 23994374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan.
    Wain J; House D; Zafar A; Baker S; Nair S; Kidgell C; Bhutta Z; Dougan G; Hasan R
    J Clin Microbiol; 2005 Mar; 43(3):1158-65. PubMed ID: 15750077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
    Jin C; Gibani MM; Moore M; Juel HB; Jones E; Meiring J; Harris V; Gardner J; Nebykova A; Kerridge SA; Hill J; Thomaides-Brears H; Blohmke CJ; Yu LM; Angus B; Pollard AJ
    Lancet; 2017 Dec; 390(10111):2472-2480. PubMed ID: 28965718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A.
    Kothari S; Kim JA; Kothari N; Jones C; Choe WS; Carbis R
    Vaccine; 2014 May; 32(21):2457-62. PubMed ID: 24631090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serodiagnosis of Salmonella enterica serovar Typhi and S. enterica serovars Paratyphi A, B and C human infections.
    Chart H; Cheasty T; de Pinna E; Siorvanes L; Wain J; Alam D; Nizami Q; Bhutta Z; Threlfall EJ
    J Med Microbiol; 2007 Sep; 56(Pt 9):1161-1166. PubMed ID: 17761477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi.
    Gao F; Swann C; Rigsby P; Rijpkema S; Lockyer K; Logan A; Bolgiano B;
    Biologicals; 2019 Jan; 57():34-45. PubMed ID: 30502020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
    Ahmadi H; Tabaraie B; Maleknia S; Shapouri R; Nejati M; Pour Mirza Gholi F; Hedayati M; Sadati M; Zahednia S; Sharifat Salmani A
    J Med Microbiol; 2013 Feb; 62(Pt 2):283-286. PubMed ID: 23105026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulotyping of Salmonella enterica serovar Typhi isolates from Pakistan: Absence of complete SPI-10 in Vi negative isolates.
    Liaquat S; Sarwar Y; Ali A; Haque A; Farooq M; Martinez-Ballesteros I; Laorden L; Garaizar J; Bikandi J
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006839. PubMed ID: 30500817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-fluorescence based Vi capsular polysaccharide detection for specific recognition of Salmonella enterica serovar Typhi in clinical samples.
    Pandey SK; Vinayaka AC; Rishi DB; Rishi P; Suri CR
    Anal Chim Acta; 2014 Sep; 841():51-7. PubMed ID: 25109861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
    Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
    Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.